A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder
about
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)Contemporary assessment and pharmacotherapy of Tourette syndromeEpilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based ReviewDo adrenergically active drugs have a role in the first-line treatment of attention-deficit/hyperactivity disorder?Safety and effectiveness of coadministration of guanfacine extended release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials.ADHD in children and adolescents.Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHDDo stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study.Clonidine extended-release: in attention-deficit hyperactivity disorder.Attention deficit/hyperactivity disorder: pharmacotherapy.Medication strategies in childhood aggression: a review.Managing attention deficit/hyperactivity disorder: unmet needs and future directionsThe treatment of severe child aggression (TOSCA) study: Design challenges.The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder.Service use patterns for adolescents with ADHD and comorbid conduct disorderPharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: clinical strategiesTop-Down Dysregulation-From ADHD to Emotional InstabilityBeyond methylphenidate: nonstimulant medications for youth with ADHD.Safety and efficacy of clonidine and clonidine extended-release in the treatment of children and adolescents with attention deficit and hyperactivity disorders.The role of alpha2-adrenergic agonists in attention-deficit/hyperactivity disorder.Review of attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder.Guanfacine extended release as adjunctive therapy to psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.Pharmacology and pharmacogenetics of pediatric ADHD with associated aggression: a review.Combination pharmacotherapy for psychiatric disorders in children and adolescents: prevalence, efficacy, risks and research needs.Psychopharmacological interventions in autism spectrum disorder.Pharmacotherapy of conduct disorder: Challenges, options and future directions.Duloxetine may improve some symptoms of attention-deficit/hyperactivity disorder.Panax ginseng may improve some symptoms of attention-deficit hyperactivity disorder.[Pharmacological treatment of impulsivity and aggressive behavior].A placebo-controlled study of lofexidine in the treatment of children with tic disorders and attention deficit hyperactivity disorder.Neuropharmacology of Attention-Deficit/Hyperactivity Disorder
P2860
Q22061981-CF1F0496-3A45-46B6-9303-06EBF99BF204Q24607941-BEE6BC0B-5CE7-4F65-B274-B02F7C31B8D7Q26743786-CFE79390-3465-4454-A9E4-5907C9834D1EQ28274915-645D6D41-590D-4E0A-B39B-24F42EF8165EQ33819957-D8E323E8-2DF4-4F99-8282-E4101101B9BCQ33898415-C01C9971-BB1E-409B-ACB2-956CB2AC79DAQ33947402-51E449B5-DDFA-47F9-9A8A-232625E4A52AQ34183741-3DB7051C-7F91-43E4-85AB-82275DB0015DQ34196989-3D0C0085-C138-4D9C-92AF-CE0F5F4AF720Q34213149-C2EE9776-0CC2-475C-B1B3-E45AC1A205EAQ34418634-65BE671D-8497-4EC7-B533-D6A25A9E8F75Q35190427-F45375B6-E622-4CEC-9258-873278A5A97CQ35575707-BF2E7703-8276-4270-9453-F49FDBCC3782Q35595839-11D2846C-F7EC-46B1-9989-4065961D2638Q36082025-5AF1A6BA-E86D-473E-BF33-64F0DAA8DE81Q36500967-51442BF8-29E9-4190-992B-B176CD9E25BDQ36740445-972A874F-336B-4019-A788-CDCB0B0576C9Q36925124-7EC670DC-5E34-4FF0-A988-80EBA373E2D2Q36968906-9335EFB2-82DD-490A-A8DD-8778C298B175Q37589039-28FD5214-3DCB-4E3F-9215-5EC6F86FC23DQ37791316-55B9CD59-A8AA-444E-9D9E-1F9F46F04A67Q37813630-B89286EE-A53F-4F16-B317-FE07F565D1BDQ38011640-709B7949-9175-4CCD-879A-AF04F7E27944Q38084902-92672B77-560C-4D75-BA4C-E8C5AC1F88D1Q38113748-DE252CEA-1234-471E-87DE-50E2E44568ADQ38739577-C2D10E77-848D-4F98-8EFF-8C7A33A949B0Q38839950-E21AF1D7-902E-4B4F-9D6C-80E9A81020CBQ42686386-1377FB44-37A4-4CDF-BB86-32203B4DB22DQ42720342-82217FEB-3A5F-42D6-B982-C81CF84C5F28Q43228395-E3D57111-5C23-432B-9C9D-C1305D8073CBQ44393742-5BF50204-6B79-489B-B3FF-1F26101017B6Q57277979-74A9525D-81FC-432C-BE34-8D7E0361B167
P2860
A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
A pilot study of methylphenida ...... al defiant or conduct disorder
@ast
A pilot study of methylphenida ...... al defiant or conduct disorder
@en
A pilot study of methylphenida ...... al defiant or conduct disorder
@nl
type
label
A pilot study of methylphenida ...... al defiant or conduct disorder
@ast
A pilot study of methylphenida ...... al defiant or conduct disorder
@en
A pilot study of methylphenida ...... al defiant or conduct disorder
@nl
prefLabel
A pilot study of methylphenida ...... al defiant or conduct disorder
@ast
A pilot study of methylphenida ...... al defiant or conduct disorder
@en
A pilot study of methylphenida ...... al defiant or conduct disorder
@nl
P2093
P2860
P1433
P1476
A pilot study of methylphenida ...... al defiant or conduct disorder
@en
P2093
D F Connor
R A Barkley
P2860
P356
10.1177/000992280003900102
P407
P577
2000-01-01T00:00:00Z